WHO ICTRP trial
The effect of letrozole and methformin on endometrial histology in patients with…
IRCT201412085563N6 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201412085563N6 |
|---|---|
| Public title | The effect of letrozole and methformin on endometrial histology in patients with disordered proliferative endometrium and simple hyperplasia utreus cancer. |
| Scientific title | Comparative effectiveness of letrozole and methformin on endometrial histology in patients with disordered proliferative endometrium and simple hyperplasia utreus cancer in alzahra hospital. |
| Primary sponsor | Vice chancellor for Research,Tabriz University Of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Patients with abnormal bleeding and endometrial proliferative and Hayprplastyk with irregular glands. Endometrial glandular hyperplasia;Endometrial glandular hyperplasia |
| Interventions | Intervention 1: In the third group with cervical cancer:Drug letrozole (made in Iran, Iran Hormone) 2.5 mg BID and 500 mg BID Metformin is prescribed for three months. Intervention 2: Group II endometrial proliferative effect:Drug letrozole… |
| Registration date | Jan 3, 2015 |
| Target size | 90 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: